We defined individuals as “positive” for the MYD88 L265P mutation when the proportion of the variant allele was in excess of the background error rate (0.47%), defined using 55 lung cancer samples (Materials and Methods, S2 Table). This evidence concerns the gene MYD88 and lung carcinoma.